Tumor Immune Microenvironment and VAF-inferred BRCA1/2 Loss of Heterozygosity in Japanese Patients With Germline BRCA1/2-mutated Breast Cancer.
- DOI
- 10.21873/anticanres.18441
- Published
- 2026 Nov
- Container
- Anticancer research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.21873/anticanres.18441,
title = {Tumor Immune Microenvironment and VAF-inferred BRCA1/2 Loss of Heterozygosity in Japanese Patients With Germline BRCA1/2-mutated Breast Cancer.},
author = {Kawamura Y and Mori K and Takeuchi F and Kawano J and Sagara Y and Kato N and Ohi Y and Hida AI and Shimizu C and Shimomura A},
year = {2026},
journal = {Anticancer research},
doi = {10.21873/anticanres.18441},
url = {https://doi.org/10.21873/anticanres.18441}
}RIS
TY - JOUR TI - Tumor Immune Microenvironment and VAF-inferred BRCA1/2 Loss of Heterozygosity in Japanese Patients With Germline BRCA1/2-mutated Breast Cancer. AU - Kawamura Y AU - Mori K AU - Takeuchi F AU - Kawano J AU - Sagara Y AU - Kato N AU - Ohi Y AU - Hida AI AU - Shimizu C AU - Shimomura A PY - 2026 JO - Anticancer research DO - 10.21873/anticanres.18441 UR - https://doi.org/10.21873/anticanres.18441 ER -
APA
Y, K., K, M., F, T., J, K., Y, S., N, K., Y, O., AI, H., C, S., & A, S. (2026). Tumor Immune Microenvironment and VAF-inferred BRCA1/2 Loss of Heterozygosity in Japanese Patients With Germline BRCA1/2-mutated Breast Cancer.. Anticancer research. https://doi.org/10.21873/anticanres.18441
Source records
- pubmed · retrieved 2026-11-10T07:53:43.491Z